Notice Number: NOT-DA-06-033
Release Date: October 2, 2006
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov)
Addiction to, or dependence on, drugs of abuse is a major public health and economic problem. Genetic and genomic studies have identified genes and gene variants that potentially modulate the fundamental biological mechanisms underpinning addictive processes. Discovery of these genes/variants, while extremely valuable, is only a first step in understanding molecular mechanisms of addiction. The National Institute on Drug Abuse (NIDA) intends to publish a Program Announcement (PA) in the fall of 2006 encouraging basic functional genomic research in two areas: 1. functional validation to determine which candidate genes/variants have an authentic role in addictive processes, and 2. detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in addiction.
For further information regarding this potential PA, please contact:
John Satterlee, Ph.D.
Program Director, National Institute on Drug Abuse
Genetics and Molecular Neurobiology Research Branch
Division of Basic Neuroscience and Behavioral Research
6001 Executive Boulevard
Bethesda, MD 20892-9555
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.